Private Capital Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-180
Closed -$5K 1969
2022
Q1
$5K Buy
+180
New +$5.11K ﹤0.01% 1520
2021
Q4
Sell
-127
Closed -$6K 2122
2021
Q3
$6K Hold
127
﹤0.01% 1518
2021
Q2
$7K Hold
127
﹤0.01% 1456
2021
Q1
$6K Buy
+127
New +$6.15K ﹤0.01% 1451
2020
Q4
Sell
-115
Closed -$4K 2086
2020
Q3
$4K Buy
+115
New +$3.91K ﹤0.01% 1556

Other funds holding HCAT

Private Capital Group's HCAT Position: Q2 2022 in Review

Private Capital Group sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 180 shares — an estimated $5K sold.

Private Capital Group first reported a position in HCAT in Q3 2020 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • Private Capital Group reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • Private Capital Group sold 180 Health Catalyst shares in Q2 2022, an estimated $5K.
  • Private Capital Group first reported a position in Health Catalyst in Q3 2020 and held it in 5 quarters.
  • Private Capital Group's Health Catalyst position peaked at $7K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.